A 48-year-old man with suspected Meniere disease has completed basic audiometry and caloric testing. His symptoms are consistent with the diagnosis, but the treating physician wants objective confirmation of endolymphatic hydrops before committing to long-term medical management. Which single investigation would best serve this purpose?

Explanation

## Objective Confirmation of Endolymphatic Hydrops in Meniere Disease **Key Point:** MRI with 4-hour delayed FLAIR (gadolinium-enhanced) is the only investigation that **directly visualizes** endolymphatic hydrops, making it the best single test for objective confirmation before committing to long-term management. ### Why Delayed FLAIR MRI is the Best Choice The stem specifically asks for **objective confirmation of endolymphatic hydrops** — a structural/anatomical endpoint. Delayed gadolinium-enhanced MRI (intratympanic or intravenous gadolinium, imaged at 4 hours on FLAIR/3D-FLAIR sequences) achieves this by: - **Gadolinium distributes into the perilymphatic space** but is excluded from the endolymphatic space (blood-labyrinth barrier) - On delayed FLAIR, the perilymph enhances brightly; the endolymph remains dark - **Enlargement of the dark endolymphatic compartment** (>1/3 of total fluid space in cochlea, >50% in vestibule) directly confirms hydrops - This is the **only test that provides anatomical, direct, visual evidence** of the pathological substrate of Meniere disease **High-Yield (Naganawa et al., 2010; Nakashima et al., 2016):** Intratympanic gadolinium + 4-hour delayed 3D-FLAIR MRI has sensitivity ~80–90% and specificity ~85–95% for endolymphatic hydrops, and is now endorsed by the Barany Society guidelines (2020) as the reference standard for imaging confirmation. ### Comparison of Confirmatory Tests | Test | Direct/Indirect | What it measures | Limitation | |---|---|---|---| | **Delayed FLAIR MRI** | **Direct** | Anatomical hydrops (endolymph volume) | Requires gadolinium; not universally available | | **ECoG** | Indirect (electrophysiological) | SP/AP ratio elevation | Does not visualize hydrops; 60–80% sensitivity | | **Glycerol dehydration test** | Indirect (functional) | Temporary hearing improvement after osmotic diuresis | Subjective endpoint; variable; not diagnostic | | **Posturography** | Indirect (functional) | Vestibular balance dysfunction | Non-specific; does not confirm hydrops | **Clinical Pearl:** ECoG (SP/AP ratio >0.4) was historically called the "gold standard" but it is an **indirect electrophysiological surrogate** — it infers hydrops from cochlear mechanics, not from direct visualization. The stem explicitly asks for **objective confirmation of endolymphatic hydrops**, which only delayed FLAIR MRI provides anatomically. This distinction is critical in modern ENT practice (Barany Society 2020 criteria; Nakashima et al., *Acta Otolaryngol*, 2016). ### Interpretation of Delayed FLAIR MRI ``` Endolymphatic Hydrops Grading (Nakashima): - Grade 0: No hydrops (endolymph ≤1/3 cochlear fluid space) - Grade 1: Mild hydrops (endolymph 1/3–1/2) - Grade 2: Significant hydrops (endolymph >1/2) ``` ### Clinical Context In this 48-year-old with clinical Meniere disease and completed basic workup, delayed FLAIR MRI would provide the **only direct, objective, anatomical confirmation** of endolymphatic hydrops — justifying long-term medical management (diuretics, sodium restriction) or surgical planning (endolymphatic sac decompression). ECoG remains a useful adjunct but does not directly visualize the pathology. **Mnemonic:** **FLAIR = Fluid Labyrinth Anatomically Images Real-hydrops.**